Brodeur, Drew R
Kmiotek, Stephen J.
The student worked with Pfizer Inc. to study the feasibility of an immobilized enzyme in the preparation of an intermediate to Glasdegib, a Phase I clinical SMO inhibitor that has shown promise in the inhibition of tumor growth for human colorectal and pancreatic cancers. The project resulted in an optimization of one immobilized resin based on the activity of the enzyme, enzyme stability in organic solvents, and reuse of the biocatalyst as well as a preliminary scale-up study utilizing AspenPlus.
Worcester Polytechnic Institute
Major Qualifying Project
Access to this report is limited to members of the WPI community. Please contact a project advisor or their department to request access
Restricted-WPI community only
Chemistry and Biochemistry
Your accessibility may vary due to other restrictions.